Navigation Links
Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
Date:8/4/2008

HOUSTON, Aug. 4 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, will present at the Canaccord Adams 28th Annual Global Growth Conference in Boston on Wednesday, August 13, 2008 at 8:00 AM EDT. Presentation slides will be available on-line at http://www.cyberonics.com by 5:00 PM EDT on Tuesday, August 12, 2008. Canaccord Adams will host a webcast of the presentation live and by replay at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYBX&item_id=18877 62. The replay will be available for 90 days following the conference. The presentation can also be accessed at http://www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

ABOUT VNS THERAPY AND CYBERONICS

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at http://www.cyberonics.com and http://www.vnstherapy.com.

CONTACT INFORMATION:

Greg Browne, CFO

Cyberonics, Inc.

100 Cyberonics Blvd.

Houston, TX 77058

Main: (281) 228-7262

Fax: (281) 218-9332

ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
2. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
3. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
4. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
5. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
6. Cyberonics Licenses Obesity-Related Patents
7. U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts
8. Caliper Life Sciences to Present at Leerink Swanns 3rd Annual Life Science Tools Roundtable Conference
9. ev3 Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
10. AtriCure to Present at the BMO Focus on Healthcare and Canaccord Adams Global Growth Conferences in August
11. Medco to Present at the BMO Capital Markets 2008 Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... CA (PRWEB) , ... March 27, 2017 , ... Janet Schloz is still in shock ... the best days I’ve had in a long time,” she said. , She thinks the ... of money that I never thought I would have to help my students.” , The ...
(Date:3/27/2017)... Switzerland (PRWEB) , ... March 27, 2017 , ... ... food industry. Conventional sodium testing methods are complicated and require expert user knowledge. ... a new analytical method dedicated to the simplified, yet highly accurate, determination of ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year ... be an opportunity for area-residents to celebrate two great years while also familiarizing ...
(Date:3/27/2017)... ... 2017 , ... Harris Communications, Inc., a leading provider of assistive technology ... the Deaf Seniors of America Conference, April 4-7 at the Hotel Westin Galleria in ... friendly staff from Harris Communications and to try out the newest assistive devices available ...
(Date:3/25/2017)... ... March 25, 2017 , ... Norland at Swissray is pleased to announce the ... subjects. The ELITE DXA has an active scan window, which is more than double ... fit in the scan area could not undergo an accurate total body bone density or ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Sophiris Bio Inc. (NASDAQ: ... clinical late-stage biopharmaceutical company developing topsalysin (PRX302) for ... reported fourth quarter and full year 2016 financial ... Key Corporate Highlights: Advanced Topsalysin ... During 2016, the Company reported successful results with ...
(Date:3/27/2017)... , March 27, 2017 BioLineRx ... and immunology, announced today that AGI-134, an immunotherapy for the ... of Agalimmune Ltd., will be featured at the upcoming ... Washington, DC to be held on ... ...
(Date:3/27/2017)... , March 27, 2017 The staggering cost ... wealthiest countries have access to the latest treatment options ... the US, many patients have inadequate or no health ... skip therapy altogether. Access to modern cancer treatment is ... countries. The mission statements of pharmaceutical ...
Breaking Medicine Technology: